BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 12606129)

  • 1. Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors.
    Goldstein M; Meller I; Issakov J; Orr-Urtreger A
    Neoplasia; 2006 May; 8(5):332-43. PubMed ID: 16790082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Array comparative genomic hybridization reveals unbalanced gain of the MYCN region in Wilms tumors.
    Schaub R; Burger A; Bausch D; Niggli FK; Schäfer BW; Betts DR
    Cancer Genet Cytogenet; 2007 Jan; 172(1):61-5. PubMed ID: 17175381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.
    Hontecillas-Prieto L; Garcia-Dominguez DJ; Vaca DP; Garcia-Mejias R; Marcilla D; Ramirez-Villar GL; Saez C; de Álava E
    Oncotarget; 2017 Feb; 8(7):11173-11186. PubMed ID: 28061436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of limited regions of genetic aberrations in patients affected with Wilms' tumor using a tiling-path chromosome 22 array.
    Benetkiewicz M; Díaz de Ståhl T; Gördör A; Pfeifer S; Wittmann S; Gessler M; Dumanski JP
    Int J Cancer; 2006 Aug; 119(3):571-8. PubMed ID: 16496407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for submicroscopic chromosomal rearrangements in Wilms tumor using whole-genome microarrays.
    Rassekh SR; Chan S; Harvard C; Dix D; Qiao Y; Rajcan-Separovic E
    Cancer Genet Cytogenet; 2008 Apr; 182(2):84-94. PubMed ID: 18406869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined cytogenetic and array-based comparative genomic hybridization analyses of Wilms tumors: amplification and overexpression of the multidrug resistance associated protein 1 gene (MRP1) in a metachronous tumor.
    Goldstein M; Rennert H; Bar-Shira A; Burstein Y; Yaron Y; Orr-Urtreger A
    Cancer Genet Cytogenet; 2003 Mar; 141(2):120-7. PubMed ID: 12606129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative genomic hybridization of Wilms' tumor.
    Rassekh SR; Rajcan-Separovic E
    Methods Mol Biol; 2013; 973():249-65. PubMed ID: 23412795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic changes of two Wilms tumors with anaplasia and a review of the literature suggesting a marker profile for therapy resistance.
    Stock C; Ambros IM; Lion T; Zoubek A; Amann G; Gadner H; Ambros PF
    Cancer Genet Cytogenet; 2002 Jun; 135(2):128-38. PubMed ID: 12127397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetics and molecular genetics of Wilms' tumor of childhood.
    Slater RM; Mannens MM
    Cancer Genet Cytogenet; 1992 Jul; 61(2):111-21. PubMed ID: 1322233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms Tumor Associated With the 9q22.3 Microdeletion Syndrome: 2 New Case Reports and a Review of The Literature.
    Cayrol J; Nightingale M; Challis J; Campbell M; Sullivan M; Heloury Y
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):e517-e520. PubMed ID: 30371535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor progression: potential role of unstable genomic changes.
    Hill RP
    Cancer Metastasis Rev; 1990 Sep; 9(2):137-47. PubMed ID: 2253313
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.